Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy.

Tofacitinib for Autoimmune Colitis from Anti-PD1 Tofacitinib is a JAK inhibitor that decreases cytokine production. In a woman with autoimmune colitis from the administration of pembrolizumab to tr...